NCT05794191
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +9 more
- Locations
-
- Pfizer New York, United States
Clinical trial condition
Explore clinical trials studying Infections, Pneumococcal. Study availability and eligibility vary by location and protocol.
NCT05794191
NCT02266277